Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index – NASDAQ
By Dr. Matthew Watson
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index NASDAQ The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ Stock Market-listed securities classified according to the Industry Classification Benchmark (ICB) as either Biotechnology or Pharmaceuticals. The NASDAQ ... NASDAQ Biotechnology Index surpasses all-time high in 1Q13Lexology (registration) |
Uncategorized
Comments Off on Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index – NASDAQ |
May 19th, 2013
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research